Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Urology is Scopus-indexed (Q3, CiteScore 2.3), WoS ESCI, DOAJ. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1661-7649Verify ISSN ↗1661-7657Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Urology | 65 / 123 | 47th | Q3 |
| Reproductive Medicine | 58 / 99 | 41st | Q3 |
| Oncology | 286 / 428 | 33rd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q3, CiteScore 2.3.
Current Urology is Q3 in Urology (rank 65 of 123), Q3 in Reproductive Medicine (rank 58 of 99) and Q3 in Oncology (rank 286 of 428), by CiteScore 2025.
Current Urology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 47th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.556, quartile Q2, with an H-index of 26.
Current Urology is published by Lippincott Williams and Wilkins. Its print ISSN is 1661-7649 and its online ISSN is 1661-7657.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Current Urology has an h-index of 33 and a 2-year mean of 1.22 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #61 of 123 Scopus journals in Urology.
Current Urology published 55 papers in 2025; its busiest recent year was 2022 with 94. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (49.5%), United States (17.3%) and Egypt (6.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.